Daily Archives: 16/10/2010

Drug Targets: PDE10

PDE10 is a novel CNS drug target for schizophrenia treatments. Biotie, in collaboration with Pfizer, has demonstrated that inhibitors of PDE10 are active in experimental models relevant for schizophrenia. Data from these studies were recently presented at the American Chemical … Continue reading

Posted in Drug developments & targets | Leave a comment

Daily IP news: 16/10/2010

Buisness method patenting from canada  [Patently O], [Canadaeast], [sympatico], [WSJ], [271 patent], [Federal Court of Canada] Lupin announces settlement with Warner Chilcott of Loestrin® 24 Fe and Femcon® Fe Patent Litigations [Lupin Press release], [Patent circle] P ara IV litigation on Treximate … Continue reading

Posted in Daily interesting IP news | Leave a comment